Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings 2024-02-28 22:03
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease 2024-02-28 21:32
RRD International is now RRD Biopharma Development 2024-02-28 21:00
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS 2024-02-28 20:47
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US 2024-02-28 20:00
Baird Medical Expands Presence in the United States 2024-02-28 18:00
The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Cancer Research 2024-02-28 17:27
The 20th International Congress on Luobing Theory Held in Shijiazhuang 2024-02-28 09:37
Vieworks Unveils Cutting-Edge X-ray Imaging Solutions at ECR 2024 2024-02-28 04:01
BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions 2024-02-28 02:30
FDA Grants Fast Track Designation to 9MW2821 2024-02-27 22:00
111 Announces Receipt of Withdrawal of Going Private Proposal 2024-02-27 21:58
Kakao Brain Unveils Labeler Project Exclusively for Medical Image preliminary report 2024-02-27 21:00
New Models of PENTAX Medical i20c Video Endoscope Series Obtain CE Marks 2024-02-27 17:00
Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China 2024-02-27 16:09
Amaris B. Clinic's Research Reveals Dynamic Skin Care Priorities Across Age Groups in Singapore 2024-02-27 15:21
Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E. 2024-02-27 12:40
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
Sengenics Corporation Announces Key Distributor in China 2024-02-27 08:30
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis 2024-02-27 07:14
1 92 93 94 95 96 963